Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma

Authors: Yee, Andrew J. ^{1, 3}, Laubach, Jacob P. ^{2, 3}, Campagnaro, Erica L. ⁴, Lipe, Brea C. ⁵, Nadeem, Omar ^{2, 3}, Friedman, Robb S. ⁶, Cole, Craig E. ⁴, O’Donnell, Elizabeth K. ^{1, 3}, Bianchi, Giada ^{2, 3}, Branagan, Andrew R. ^{1, 3}, Schlossman, Robert L. ^{2, 3}, Shapiro, Samantha J. ¹, Harrington, Cynthia C. ¹, Burke, Jill N. ¹, Gammon, Marilyn T. ¹, Lively, Kathleen J. ¹, Reimonn, Cassandra A. ¹, Andrade, Danielle X. ¹, Redd, Robert ², Lohr, Jens G. ^{2, 3}, Anderson, Kenneth C. ^{2, 3}, Richardson, Paul G. ^{2, 3}, Raje, Noopur S. ^{1, 3, ∗}

Source: In Blood Advances 11 March 2025 9(5):1163-1170

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

Authors: Looka, Andrew ¹, Qualls, David A. ^{1, ∗}, Matthews, Daniel ¹, Redd, Robert A. ², Sakellis, Christopher ³, Duffy, Caitlyn ¹, Dela Cruz, Jamie ¹, Saucier, Anna ¹, Armand, Philippe ¹, Crombie, Jennifer L. ¹, Fisher, David C. ¹, Jacobsen, Eric D. ¹, Kim, Austin I. ¹, LaCasce, Ann S. ¹, Merryman, Reid W. ¹, Parry, Erin M. ¹, Jacobson, Caron A. ¹

Source: In Blood Advances 11 February 2025 9(3):455-462

Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy

Authors: Juhasz, Vencel ^{a, b}, Quinaglia, Thiago ^a, Drobni, Zsofia D. ^b, Heemelaar, Julius C. ^a, Neuberg, Donna S. ^c, Han, Yuchi ^d, Ky, Bonnie ^d, Kwong, Raymond Y. ^e, Januzzi, James L. ^{f, g}, Asnani, Aarti ^h, Redd, Robert A. ^c, Mousavi, Negareh ⁱ, Jerosch-Herold, Michael ^j, Scherrer-Crosbie, Marielle ^d, Neilan, Tomas G. ^{a, f, ∗}

Source: In JACC: CardioOncology February 2025 7(2):125-137

Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes

Authors: How, Joan ^{1, ∗}, Leiva, Orly ², Redd, Robert ³, Marneth, Anna E. ⁴, DeAngelo, Daniel J. ⁵, Dieli-Conwright, Christina M. ⁶, El-Jawahri, Areej ⁷, Kamaz, Barensel ¹, Kim, Chulwoo ¹, Lindsley, Coleman ⁵, Luskin, Marlise ⁵, Stahl, Maximilian ⁵, Wazir, Mohammed ⁸, Weeks, Lachelle D. ⁵, Hobbs, Gabriela ⁷

Source: In Blood Vessels, Thrombosis & Hemostasis December 2024

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma

Authors: Maurer, Katie ^{1, 2, 3}, Grabski, Isabella N. ⁴, Houot, Roch ^{1, 5}, Gohil, Satyen H. ^{1, 6, 7}, Miura, Shogo ¹, Redd, Robert ⁴, Lyu, Haoxiang ^{1, 8}, Lu, Wesley ^{1, 8}, Arihara, Yohei ¹, Budka, Justin ⁹, McDonough, Mikaela ¹, Ansuinelli, Michela ¹, Reynolds, Carol ¹, Jacene, Heather ^{2, 10}, Li, Shuqiang ^{1, 3, 8}, Livak, Kenneth J. ^{1, 8}, Ritz, Jerome ^{1, 2}, Miles, Brodie ⁹, Mattie, Mike ⁹, Neuberg, Donna S. ¹¹, Irizarry, Rafael A. ^{4, 11}, Armand, Philippe ^{1, 2}, Wu, Catherine J. ^{1, 2, 3}, Jacobson, Caron ^{1, 2, ∗}

Source: In Blood 12 December 2024 144(24):2490-2502

Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis

Authors: Venkat, Rathnam K. ¹, Redd, Robert A. ², Harris, Amyah C. ³, Aryee, Martin J. ^{2, 4}, Marneth, Anna E. ^{5, 6}, Kamaz, Baransel ⁶, Kim, Chulwoo J. ⁶, Wazir, Mohammed ⁷, Weeks, Lachelle D. ³, Stahl, Maximilian ³, DeAngelo, Daniel J. ³, Lindsley, R. Coleman ³, Luskin, Marlise R. ³, Hobbs, Gabriela S. ⁸, How, Joan ^{3, 6, ∗}

Source: In Blood Advances 10 December 2024 8(23):6043-6054

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population

Authors: Lee, David J., El-Khoury, Habib, Tramontano, Angela C., Alberge, Jean-Baptiste, Perry, Jacqueline, Davis, Maya I., Horowitz, Erica, Redd, Robert, Sakrikar, Dhananjay, Barnidge, David, Perkins, Mark C., Harding, Stephen, Mucci, Lorelei, Rebbeck, Timothy R., Ghobrial, Irene M., Marinac, Catherine R.

Source: In Blood Advances 9 April 2024 8(7):1737-1746

DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma

Authors: Chapuy, Björn ^{1, 2, 3, 7, ∗}, Wood, Timothy ⁴, Stewart, Chip ⁴, Dunford, Andrew ⁴, Wienand, Kirsty ^{1, 4}, Khan, Sumbul Jawed ¹, Serin, Nazli ³, Wang, Meng ³, Calabretta, Eleonora ¹, Shimono, Joji ³, Van Seters, Samantha ⁴, Wisemann, Sam ⁴, Belkin, Saveliy ⁴, Heimann, David ⁴, Redd, Robert ⁵, Shipp, Margaret A. ^{1, 2, ∗∗}, Getz, Gad ^{2, 4, 6, ∗∗∗}

Source: In Blood December 2024

MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8

Authors: Mandato, Elisa, Yan, Qingsheng, Ouyang, Jing, Paczkowska, Julia, Qin, Yan, Hao, Yansheng, Bojarczuk, Kamil, Hansen, Julia, Chapuy, Björn, Rodig, Scott J., Khan, Sumbul Jawed, Redd, Robert A., Shipp, Margaret A.

Source: In Blood 5 October 2023 142(14):1219-1232

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

Authors: Merryman, Reid W., Redd, Robert A., Taranto, Eleanor, Ahmed, Gulrayz, Jeter, Erin, McHugh, Kristin M., Brown, Jennifer R., Crombie, Jennifer L., Davids, Matthew S., Fisher, David C., Freedman, Arnold S., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Ng, Samuel Y., Odejide, Oreofe O., Parry, Erin M., Jacene, Heather, Park, Hyesun, Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Shipp, Margaret A., Herrera, Alex F., Armand, Philippe

Source: In Blood Advances 12 September 2023 7(17):4748-4759

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Authors: Merrill, Mwanasha H., Dahi, Parastoo B., Redd, Robert A., McDonough, Mikaela M., Chen, Yi-Bin, DeFilipp, Zachariah, Herrera, Alex F., Fisher, David C., LaCasce, Ann S., Odejide, Oreofe O., Ng, Samuel Y., Jacobson, Caron A., Merryman, Reid W., Kim, Austin I., Nieto, Yago L., Sauter, Craig S., Shah, Gunjan L., Zain, Jasmine M., Armand, Philippe, Jacobsen, Eric D.

Source: In Blood 17 August 2023 142(7):621-628

Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma

Authors: Abramson, Jeremy S., Bengston, Elizabeth, Redd, Robert, Barnes, Jeffrey A., Takvorian, Tak, Sokol, Lubomir, Lansigan, Frederick, Armand, Philippe, Shah, Bijal, Jacobsen, Eric, Martignetti, Rosalba, Turba, Elyce, Metzler, Sara, Patterson, Victoria, LaCasce, Ann S., Bello, Celeste M.

Source: In Blood Advances 11 April 2023 7(7):1130-1136

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Authors: Cowan, Annie ^*, Ferrari, Federico ^*, Freeman, Samuel S, Redd, Robert, El-Khoury, Habib, Perry, Jacqueline, Patel, Vidhi, Kaur, Priya, Barr, Hadley, Lee, David J, Lightbody, Elizabeth, Downey, Katelyn, Argyelan, David, Theodorakakou, Foteini, Fotiou, Despina, Liacos, Christine Ivy, Kanellias, Nikolaos, Chavda, Selina J, Ainley, Louise, Sandecká, Viera, Pospíšilová, Lenka, Minarik, Jiri, Jungova, Alexandra, Radocha, Jakub, Spicka, Ivan, Nadeem, Omar, Yong, Kwee, Hájek, Roman, Kastritis, Efstathios, Marinac, Catherine R, Dimopoulos, Meletios A, Getz, Gad, Trippa, Lorenzo ^†, Ghobrial, Irene M ^{†, *}

Source: In The Lancet Haematology March 2023 10(3):e203-e212

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Authors: Sklavenitis-Pistofidis, Romanos, Aranha, Michelle P., Redd, Robert A., Baginska, Joanna, Haradhvala, Nicholas J., Hallisey, Margaret, Dutta, Ankit K., Savell, Alexandra, Varmeh, Shohreh, Heilpern-Mallory, Daniel, Ujwary, Sylvia, Zavidij, Oksana, Aguet, Francois, Su, Nang K., Lightbody, Elizabeth D., Bustoros, Mark, Tahri, Sabrin, Mouhieddine, Tarek H., Wu, Ting, Flechon, Lea, Anand, Shankara, Rosenblatt, Jacalyn M., Zonder, Jeffrey, Vredenburgh, James J., Boruchov, Adam, Bhutani, Manisha, Usmani, Saad Z., Matous, Jeffrey, Yee, Andrew J., Jakubowiak, Andrzej, Laubach, Jacob, Manier, Salomon, Nadeem, Omar, Richardson, Paul, Badros, Ashraf Z., Mateos, Maria-Victoria, Trippa, Lorenzo, Getz, Gad, Ghobrial, Irene M.

Source: In Cancer Cell 14 November 2022 40(11):1358-1373

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study

Authors: El-Khoury, Habib, Lee, David J, Alberge, Jean-Baptiste, Redd, Robert, Cea-Curry, Christian J, Perry, Jacqueline, Barr, Hadley, Murphy, Ciara, Sakrikar, Dhananjay, Barnidge, David, Bustoros, Mark, Leblebjian, Houry, Cowan, Anna, Davis, Maya I, Amstutz, Julia, Boehner, Cody J, Lightbody, Elizabeth D, Sklavenitis-Pistofidis, Romanos, Perkins, Mark C, Harding, Stephen, Mo, Clifton C, Kapoor, Prashant, Mikhael, Joseph, Borrello, Ivan M, Fonseca, Rafael, Weiss, Scott T, Karlson, Elizabeth, Trippa, Lorenzo, Rebbeck, Timothy R, Getz, Gad, Marinac, Catherine R, Ghobrial, Irene M

Source: Lancet.Haematology. 9(5):e340-e349

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183247424.0x000001&indx=1&recIds=ETOCvdc_100183247424.0x000001

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia

Authors: Weeks, Lachelle D., Marinac, Catherine R., Redd, Robert, Abel, Gregory, Lin, Amy, Agrawal, Mridul, Stone, Richard M., Schrag, Deborah, Ebert, Benjamin L.

Source: Blood. 139(8):1246-1250

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183249353.0x000001&indx=1&recIds=ETOCvdc_100183249353.0x000001

Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation

Authors: Taranto, Eleanor, Redd, Robert, Jeter, Erin, McHugh, Kristin, Crombie, Jennifer L., Fisher, David C., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Odejide, Oreofe O., Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Bonjoc, Kimberley-Jane C., Chaudhry, Ammar, Herrera, Alex F., Armand, Philippe, Merryman, Reid W.

Source: Leukemia & lymphoma. 63(12):2912-2917

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173039611.0x000001&indx=1&recIds=ETOCvdc_100173039611.0x000001

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.

Authors: Nadeem, Omar, Aranha, Michelle P., Redd, Robert, Timonian, Michael, Magidson, Sophie, Lightbody, Elizabeth D., Alberge, Jean-Baptiste, Bertamini, Luca, Dutta, Ankit K., El-Khoury, Habib, Bustoros, Mark, Laubach, Jacob P., Bianchi, Giada, O'Donnell, Elizabeth, Wu, Ting, Tsuji, Junko, Anderson, Kenneth C., Getz, Gad, Trippa, Lorenzo, Richardson, Paul G.

Source: Nature Communications; 1/3/2025, Vol. 16 Issue 1, p1-17, 17p

Subject Terms: T cells, GENE expression, PROGRESSION-free survival, RNA sequencing, MULTIPLE myeloma

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study

Authors: Haydu, J. Erika, Maron, Jenny S., Redd, Robert A., Gallagher, Kathleen M.E., Fischinger, Stephanie, Barnes, Jeffrey A., Hochberg, Ephraim P., Johnson, P. Connor, Takvorian, R.W., Katsis, Katelin, Portman, Daneal, Ruiters, Jade, Sechio, Sidney, Devlin, Mary, Regan, Connor, Blumenthal, Kimberly G., Banerji, Aleena, Judd, Allen D., Scorsune, Krista J., McGree, Brianne M., Sherburne, Maryanne M., Lynch, Julia M., Weitzman, James I., Lei, Matthew, Kotton, Camille N., Dighe, Anand S., Maus, Marcela V., Alter, Galit, Abramson, Jeremy S. ^*, Soumerai, Jacob D. ^{*, *}

Source: In Blood Advances 22 March 2022 6(6):1671-1683

Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes.

Authors: Redd, Robert A.¹, Ford, Josie², Lei, Matthew³, Abramson, Jeremy S.², Soumerai, Jacob D.² jsoumerai@mgh.harvard.edu

Source: Leukemia & Lymphoma. Dec2023, Vol. 64 Issue 14, p2296-2305. 10p.

Subject Terms: *BRUTON tyrosine kinase, *ATRIAL fibrillation